| Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling DJ Junk, BL Bryson, JM Smigiel, N Parameswaran, CA Bartel, ... Oncogene 36 (28), 4001-4013, 2017 | 146 | 2017 |
| Potent EMT and CSC phenotypes are induced by oncostatin-M in pancreatic cancer JM Smigiel, N Parameswaran, MW Jackson Molecular Cancer Research 15 (4), 478-488, 2017 | 88 | 2017 |
| Lack of ICAM-1 on APCs during T cell priming leads to poor generation of central memory cells N Parameswaran, R Suresh, V Bal, S Rath, A George The Journal of Immunology 175 (4), 2201-2211, 2005 | 67 | 2005 |
| Neutrophil expression of Fas ligand and perforin directs effector CD8 T cell infiltration into antigen-challenged skin DD Kish, AV Gorbachev, N Parameswaran, N Gupta, RL Fairchild The Journal of Immunology 189 (5), 2191-2202, 2012 | 62 | 2012 |
| Conformational switching in ezrin regulates morphological and cytoskeletal changes required for B cell chemotaxis N Parameswaran, K Matsui, N Gupta The Journal of Immunology 186 (7), 4088-4097, 2011 | 57 | 2011 |
| Re‐defining ERM function in lymphocyte activation and migration N Parameswaran, N Gupta Immunological reviews 256 (1), 63-79, 2013 | 51 | 2013 |
| Spatial coupling of JNK activation to the B cell antigen receptor by tyrosine-phosphorylated ezrin N Parameswaran, G Enyindah-Asonye, N Bagheri, NB Shah, N Gupta The Journal of Immunology 190 (5), 2017-2026, 2013 | 46 | 2013 |
| FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance CA Bartel, N Parameswaran, R Cipriano, MW Jackson Oncotarget 7 (32), 52597, 2016 | 44 | 2016 |
| Ezrin tunes the magnitude of humoral immunity D Pore, N Parameswaran, K Matsui, MB Stone, I Saotome, AI McClatchey, ... The Journal of Immunology 191 (8), 4048-4058, 2013 | 39 | 2013 |
| Cutting edge: ezrin regulates inflammation by limiting B cell IL-10 production D Pore, K Matsui, N Parameswaran, N Gupta The Journal of Immunology 196 (2), 558-562, 2016 | 31 | 2016 |
| Targeting pancreatic cancer cell plasticity: The latest in therapeutics JM Smigiel, N Parameswaran, MW Jackson Cancers 10 (1), 14, 2018 | 29 | 2018 |
| Cellular prion protein mediates pancreatic cancer cell survival and invasion through association with and enhanced signaling of Notch1 Y Wang, S Yu, D Huang, M Cui, H Hu, L Zhang, W Wang, ... The American journal of pathology 186 (11), 2945-2956, 2016 | 29 | 2016 |
| A FAM83A positive feed-back loop drives survival and tumorigenicity of pancreatic ductal adenocarcinomas N Parameswaran, CA Bartel, W Hernandez-Sanchez, KL Miskimen, ... Scientific reports 9 (1), 13396, 2019 | 27 | 2019 |
| CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression S Yu, N Parameswaran, M Li, Y Wang, MW Jackson, H Liu, W Xin, L Zhou Oncotarget 8 (32), 52432, 2016 | 21 | 2016 |
| Oral tolerance in T cells is accompanied by induction of effector function in lymphoid organs after systemic immunization N Parameswaran, DJ Samuvel, R Kumar, S Thatai, V Bal, S Rath, ... Infection and immunity 72 (7), 3803-3811, 2004 | 15 | 2004 |
| Proteomics analysis of the ezrin interactome in B cells reveals a novel association with Myo18aα K Matsui, N Parameswaran, N Bagheri, B Willard, N Gupta Journal of proteome research 10 (9), 3983-3992, 2011 | 14 | 2011 |
| Cutting edge: deletion of Ezrin in B cells of lyn-deficient mice downregulates lupus pathology D Pore, E Huang, D Dejanovic, N Parameswaran, MB Cheung, N Gupta The Journal of Immunology 201 (5), 1353-1358, 2018 | 13 | 2018 |
| Aberrant induction of a mesenchymal/stem cell program engages senescence in normal mammary epithelial cells BL Bryson, I Tamagno, SE Taylor, N Parameswaran, NM Chernosky, ... Molecular Cancer Research 19 (4), 651-666, 2021 | 11 | 2021 |
| A pilot clinical trial of oral tetrahydrouridine/decitabine for noncytotoxic epigenetic therapy of chemoresistant lymphoid malignancies B Hill, D Jagadeesh, B Pohlman, R Dean, N Parameswaran, J Chen, ... Seminars in hematology 58 (1), 35-44, 2021 | 9 | 2021 |
| CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma N Parameswaran, L Luo, L Zhang, J Chen, FP DiFilippo, C Androjna, ... Leukemia 37 (10), 2050-2057, 2023 | 8 | 2023 |
